We have collected information about Targeted Drug Delivery In Pancreatic Cancer for you. Follow the links to find out details on Targeted Drug Delivery In Pancreatic Cancer.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815202/
Targeted therapy using CA125 and maybe in combination with mesothelin could be a promising strategy for drug delivery in pancreatic cancer. Stem cell markers Tumors contain a few embryonic-like cells, known as cancer stem cells or cancer-initiating cells (CIC), which count for primary and metastatic tumor growth.
https://www.sciencedirect.com/science/article/pii/S0304419X09000729
Review Targeted drug delivery in pancreatic cancer 1. Introduction. Pancreatic cancer has the worst mortality rate and the lowest overall survival (OS)... 2. Therapeutic agents. In addition to the conventional chemotherapy drugs such as gemcitabine,... 3. Drug delivery methods. The most commonly ...Author: Xianjun Yu, Yuqing Zhang, Changyi Chen, Qizhi Yao, Min Li
https://www.cancer.org/cancer/pancreatic-cancer/treating/targeted-therapy.html
Erlotinib (Tarceva) is a drug that targets a protein on cancer cells called EGFR, which normally helps the cells grow. In people with advanced pancreatic cancer, this drug can be given along with the chemo drug gemcitabine. Some people may benefit more from this combination than others.
http://europepmc.org/articles/PMC2815202
Jan 01, 2010 · Targeted therapy against specific markers in pancreatic cancer, or targeted drug delivery which use specific markers in pancreatic cancer to deliver chemotherapy or other drugs may significantly improve the current therapies for pancreatic cancer treatment.
https://www.researchgate.net/publication/38033109_Targeted_Drug_Delivery_in_Pancreatic_Cancer
Despite significant preclinical data, there are currently very few clinical trials involving pancreatic cancer targeted drug delivery. This article summarizes current developments in targeted...
https://cancerres.aacrjournals.org/content/79/24_Supplement/B26
Dec 15, 2019 · Targeted and sustained drug delivery therapy for localized pancreatic cancer: In vivo validation in porcine models [abstract]. In: Proceedings of the AACR Special Conference on Pancreatic Cancer: Advances in Science and Clinical Care; 2019 Sept 6-9; Boston, MA.Author: Margaret Lashof-Sullivan, Amanda L. McSweeney, David T. Ting, Michael P. Kim, Ching-Wei D. Tzeng, La...
Searching for Targeted Drug Delivery In Pancreatic Cancer?
You can just click the links above. The data is collected for you.
